Author:
Udompap Prowpanga,Kim W. Ray
Reference109 articles.
1. Abramson JS, Chung RT. Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma. JAMA. 2014;312(23):2505–7.
2. Abrao JM, Carvalho MF, Garcia PD, Contti MM, Andrade LG. Safety of kidney transplantation using anti-HBc-positive donors. Transplant Proc. 2014;46(10):3408–11.
3. Ahmed A, Keeffe EB. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. Am J Gastroenterol. 1999;94(1):249–51.
4. American Association for the Study of Liver Diseases Emergin Trends Conference. Reactivation of Hepatitis B. March 21–22, 2013; Arlington, VA, 2013.
5. Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, et al. Prevention and treatment of cancer-related infections. J Natl Compr Cancer Netw. 2012;10(11):1412–45.